GLP-1 research emerges
Developing research highlights the clinical impact of glucagon-like peptide-1 receptor agonists (GLP-1RA), including their potential role in cancer risk reduction and skin ageing. A study published in Annals of Oncology
Developing research highlights the clinical impact of glucagon-like peptide-1 receptor agonists (GLP-1RA), including their potential role in cancer risk reduction and skin ageing. A study published in Annals of Oncology